$JNJ

AI 分析

生成於 May 18, 2026

AI Score
71/ 100
Hold$JNJ

Johnson & Johnson

$JNJNYSEHealthcareMega-Cap

Johnson & Johnson researches, develops, manufactures, and sells various products in the healthcare field worldwide.

Market Cap
$380B
Revenue (TTM)
$88.5B
+4.5%
Net Income (TTM)
$18.2B
+6.8%
EPS (TTM)
$7.58
P/E Ratio
21.2
Dividend Yield
3.0%
52-Week Range
$145-$172
Beta
0.52
Dimension Scores
Fundamental
76
Technical
65
Sentiment
70
Risk / Reward
74
Momentum
62
FundTechSentRiskMome
Financial Health
Profitability
80strong
Growth
62moderate
Liquidity
78moderate
Solvency
75moderate
Efficiency
78moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $JNJ

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。